Curis (CRIS) Goodwill & Intangibles (2010 - 2026)
Curis' (CRIS) quarterly Goodwill & Intangibles came in at $9.0 million in Q1 2026, little changed YoY from $9.0 million in Q1 2025, and little changed on a QoQ basis from $9.0 million in Q4 2025.
Curis (CRIS) Goodwill & Intangibles (2010 - 2026) Analysis & Trends
Curis (CRIS) has 17 years of Goodwill & Intangibles data on file, last reported at $9.0 million in Q1 2026.
- Quarterly Goodwill & Intangibles changed 0.0% year-over-year to $9.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $9.0 million (changed 0.0% YoY) and the FY2025 annual result came in at $9.0 million, changed 0.2% from the prior year.
- Goodwill & Intangibles held at $9.0 million in Q1 2026, from $9.0 million in the prior quarter.
- In the past five years, Goodwill & Intangibles ranged from a high of $9.0 million in Q4 2023 to a low of $9.0 million in Q1 2022.
- A 5-year average of $9.0 million and a median of $9.0 million in 2022 frame the typical range for Goodwill & Intangibles.
- Annual changes were most pronounced in 2023 — Goodwill & Intangibles gained 0.2% — and 2025, when it declined 0.2%.
- Tracing CRIS's Goodwill & Intangibles over 5 years: stood at $9.0 million in 2022, then gained by 0.2% to $9.0 million in 2023, then changed by 0.0% to $9.0 million in 2024, then declined by 0.2% to $9.0 million in 2025, then changed by 0.0% to $9.0 million in 2026.
- The last three Goodwill & Intangibles figures came in at $9.0 million (Q1 2026), $9.0 million (Q4 2025), and $9.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Curis | 3.27 Mn | -2.35 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.98 Mn |
| Dec 31, 2025 | 8.98 Mn |
| Sep 30, 2025 | 8.98 Mn |
| Jun 30, 2025 | 8.98 Mn |
| Mar 31, 2025 | 8.98 Mn |
| Dec 31, 2024 | 9.00 Mn |
| Sep 30, 2024 | 8.98 Mn |
| Jun 30, 2024 | 8.98 Mn |
| Mar 31, 2024 | 8.98 Mn |
| Dec 31, 2023 | 9.00 Mn |
| Sep 30, 2023 | 8.98 Mn |
| Jun 30, 2023 | 8.98 Mn |
| Mar 31, 2023 | 8.98 Mn |
| Dec 31, 2022 | 8.98 Mn |
| Sep 30, 2022 | 8.98 Mn |
| Jun 30, 2022 | 8.98 Mn |
| Mar 31, 2022 | 8.98 Mn |
| Dec 31, 2021 | 8.98 Mn |
| Sep 30, 2021 | 8.98 Mn |
| Jun 30, 2021 | 8.98 Mn |